News

Meaningful Momentum | A New Year Letter from our Executive Director

Friends, Each year brings the fresh promise of new opportunities and possibilities. As we begin our 33rd year in operation, we are energized by your overwhelming support, especially over the past several years. We continue to make meaningful momentum in all areas of the clinic and we couldn’t do this work without you. Our clinical, laboratory, and research […]

Read more

2022 Clinic for Special Children Informational Brochure

New year, new brochure! We’ve updated and expanded our Clinic for Special Children informational brochure for 2022. Learn more about our services, key stats, what makes us unique, and how we offer affordable and accessible care. To view the updated brochure, visit HERE.

Read more

New Clinical Educational Series | Caring for the Plain Community

A new educational series tailored for physicians serving the Plain community is here! This bimonthly, virtual learning series will occur every other month on the first Friday from noon – 1 p.m. The talk series is organized by a collaboration of WellSpan Health, the Clinic for Special Children, and Penn Medicine Lancaster General Health. The […]

Read more

A Birthday of Hope | Oakley Zimmerman’s Story

The Zimmerman family shared their story about how they were met with compassion and action at the Clinic for Special Children for our Annual Giving Appeal. You can read their story below, a letter from our board chairman, and give to the Clinic to help support those with rare genetic disorders, like Oakley. The Zimmerman […]

Read more

Over $106,000 raised for the Clinic during the 2021 Extraordinary Give!

  On Friday, November 19, 2021 over 250 Extraordinary people donated to the Clinic for Special Children and raised over $106,000 for children and adults with rare genetic disorders! Your support this allows our team to provide affordable, compassionate care to the families that we serve. The Extraordinary Give is Lancaster County’s largest day of online […]

Read more

2021 Extraordinary Give | Support the Clinic on Friday, November 19th!

You can help make an EXTRAORDINARY difference! We’re counting down the days until the Extraordinary Give on Friday, November 19th – Lancaster County’s largest day of online giving! Last year Clinic for Special Children supporters helped raise over $55,000! We will have $25,000 in matching dollars this year thanks to generous sponsors! Help us unlock these matching dollars and make […]

Read more

Dr. Erik G. Puffenberger writes article detailing history of genetic investigation and discovery at the Clinic

Dr. Erik G. Puffenberger, Laboratory Director at the Clinic, recently penned an article, “Mendelian disease research in the Plain populations of Lancaster County, Pennsylvania”, for the American Journal of Medical Genetics. Dr. Puffenberger joined the Clinic in 1998 and has witnessed first-hand the evolution of research and translational medicine at the Clinic for Special Children. […]

Read more

Safety and efficacy data published for novel nusinersen drug delivery method for spinal muscular atrophy patients

STRASBURG, PA – A recently published paper details the safety and efficacy of nusinersen administration via a subcutaneous intrathecal catheter system (SIC) for SMA patients with advanced disease. SMA is a devastating genetic disease that leads to progressive degeneration of motor neurons that control movement, swallowing, and breathing. The novel SIC system is comprised of […]

Read more

Enjoy our Fall 2021 Newsletter!

The journey to a rare genetic diagnosis can be a long odyssey for many families. In our latest edition of the Clinic for Special Children newsletter, read a story of a family living with an ultra rare disorder, learn about our genetic testing pipeline at the Clinic, and see how we’ve worked with collaborators to […]

Read more

Dr. Kevin A. Strauss author on largest published safety study for Spinal Muscular Atrophy (SMA) gene therapy

Dr. Kevin A. Strauss, Medical Director at the Clinic for Special Children, was an author on a recently published research paper, Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy. This paper explores safety for onasemonogene abeparvovec therapy (gene therapy for Spinal Muscular Atrophy). The study is the largest international safety study published thus far. […]

Read more